Therapeutic targeting of CD6 in autoimmune diseases: A review of Cuban clinical studies with the antibodies IOR-T1 and itolizumab
| Contribuinte(s) |
Hernández, P., Division of Clinical Research, Center of Molecular Immunology, Havana, Cuba Moreno, E., Division of Product Development, Center of Molecular Immunology, Havana, Cuba, Universidad de Medellin, Medellin, Colombia Aira, L.E., Division of Clinical Research, Center of Molecular Immunology, Havana, Cuba Rodríguez, P.C., Division of Clinical Research, Center of Molecular Immunology, Havana, Cuba |
|---|---|
| Data(s) |
2016
27/07/2016
27/07/2016
|
| Identificador |
13894501 |
| Idioma(s) |
eng |
| Publicador |
Bentham Science Publishers B.V. |
| Relação |
Current Drug Targets Volume 17, Issue 6, 1 May 2016, Pages 666-677 http://www.eurekaselect.com/138932/article |
| Direitos |
info:eu-repo/semantics/restrictedAccess restrictedAccess |
| Fonte |
Scopus |
| Tipo |
info:eu-repo/semantics/article Article |
